1. Academic Validation
  2. N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor

N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines: the first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor

  • Bioorg Med Chem. 2007 Apr 1;15(7):2514-27. doi: 10.1016/j.bmc.2007.01.055.
Pier Giovanni Baraldi 1 Delia Preti Mojgan Aghazadeh Tabrizi Francesca Fruttarolo Giulia Saponaro Stefania Baraldi Romeo Romagnoli Allan R Moorman Stefania Gessi Katia Varani Pier Andrea Borea
Affiliations

Affiliation

  • 1 Dipartimento di Scienze Farmaceutiche, Università di Ferrara, 44100 Ferrara, Italy. [email protected]
Abstract

A new series of N(6)-[(hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2-chloro)-5'-N-ethylcarboxamido-adenosines (24-43) has been synthesised and tested in binding assays at hA(1), hA(2A) and hA(3) adenosine receptors, and in a functional assay at the hA(2B) subtype. The examined compounds displayed high potency in activating A(2B) receptors with good selectivity versus A(2A) subtypes. The introduction of an unsubstituted 4-[(phenylcarbamoyl)-methoxy]-phenyl chain at the N(6) position of 5'-N-ethylcarboxamido-adenosine led us to the recognition of compound 24 as a full agonist displaying the highest efficacy of the series (EC(50) hA(2B)=7.3 nM). These compounds represent the first report about adenosine-related structures capable of activating hA(2B) subtype in the low nanomolar range.

Figures
Products